These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9139686)

  • 1. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
    Dorn GW; Davis MG; D'Angelo DD
    J Biol Chem; 1997 May; 272(19):12399-405. PubMed ID: 9139686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP.
    D'Angelo DD; Terasawa T; Carlisle SJ; Dorn GW; Lynch KR
    Prostaglandins; 1996 Oct; 52(4):303-16. PubMed ID: 8936585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
    Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
    J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
    Habib A; FitzGerald GA; Maclouf J
    J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
    Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
    Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
    Sessa WC; Halushka PV; Okwu A; Nasjletti A
    Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
    D'Angelo DD; Eubank JJ; Davis MG; Dorn GW
    J Biol Chem; 1996 Mar; 271(11):6233-40. PubMed ID: 8626415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
    Dorn GW
    J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells.
    Qiao N; Reynaud D; Demin P; Halushka PV; Pace-Asciak CR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1142-7. PubMed ID: 14560042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW
    J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
    Shin Y; Romstedt KJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
    Dorn GW
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
    Schrör K; Davis-Bruno K; Halushka PV
    Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
    D'Angelo DD; Davis MG; Ali S; Dorn GW
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1034-41. PubMed ID: 7965765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
    Senchyna M; Crankshaw DJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
    Dorn GW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.